Form 4: Zimmer Biomet Director Farrell Reports Acquisition of Phantom Stock Units and Restricted Stock Units

Director Michael J. Farrell reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.

Summary

• Michael J. Farrell, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of phantom stock units and restricted stock units on May 10, 2024.
• The phantom stock units, acquired under the Deferred Compensation Plan for Non-Employee Directors, amounted to 616.726 units at a price of $121.61.
• These units will be settled in shares of Company common stock within sixty days after cessation of service as a Director.
• Farrell also acquired 1,068.991 restricted stock units, which are immediately 100% vested but subject to mandatory deferral until the later of termination of service as a Director or three years after the grant date.
• Following these transactions, Farrell beneficially owns 14,286.627 phantom stock units and 10,831.928 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock unit acquisitions, indicating alignment of interests but not necessarily a strong positive or negative signal.

Positives

• The acquisition of stock units by a director signals confidence in the company's future performance.
• The vesting and deferral terms of the restricted stock units align the director's interests with the long-term success of the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be indicative of their confidence in the company's prospects. This filing is specific to Zimmer Biomet, a major player in the medical device industry, particularly in orthopedics.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies to align the interests of executives and directors with those of shareholders.
• The vesting schedules and deferral periods for restricted stock units are generally in line with industry standards, often ranging from one to five years.
• Companies like Stryker and Johnson & Johnson also utilize similar compensation structures for their executives and directors.

Stakeholder Impact

• The acquisition of stock units by a director can positively influence shareholder sentiment, as it demonstrates confidence in the company's future.

Key Dates